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Abstract Heavy drinking is prevalent among people living
with HIV. Studies use tools like patient-reported outcomes
(PROs) to quantify alcohol use in a detailed, timely man-
ner. However, if alcohol misuse influences PRO comple-
tion, selection bias may result. Our study included 14,145
adult HIV patients (133,036 visits) from CNICS who were
eligible to complete PROs at an HIV primary care visit. We
compared PRO completion proportions between patients
with and without a clinical diagnosis of at-risk alcohol use
in the prior year. We accounted for confounding by base-
line and visit-specific covariates. PROs were completed at
20.8% of assessed visits. The adjusted difference in PRO
completion proportions was -3.2% (95% CI -5.6 to
-0.8%). The small association between receipt of an at-
risk alcohol use diagnosis and decreased PRO completion
suggests there could be modest selection bias in studies
using the PRO alcohol measure.
Keywords Patient-reported outcomes  PROs  HIV 
Alcohol consumption  Selection bias
Introduction
In the United States, people living with human immunod-
eficiency virus (HIV) exhibit a higher prevalence of heavy
drinking and alcohol use disorders than the general popu-
lation [1–3]. Long-term heavy drinking has been linked to
worsened health in HIV-positive populations, through such
mechanisms as immune dysregulation and decreased
adherence to antiretroviral therapy (ART) [1, 3–5]. To
inform alcohol interventions in these populations, it is
critical that future work examine the relationship between
alcohol consumption and HIV outcomes like mortality or
viremia. Before these relationships can be examined,
though, we must assess the measurement properties of the
metrics used to estimate alcohol intake. Here, we examine
whether using patient-reported outcome (PRO) question-
naires that measure alcohol consumption would likely
provide valid estimates of the effects of alcohol in the
Center for AIDS Research (CFAR) Network of Integrated
Clinical Systems (CNICS), a large, geographically diverse
HIV cohort.
PROs are an increasingly powerful tool for collecting
rich, timely data [6–8]. Patient responses recorded using
individual tablet computers (a common means of collecting
PROs) are expected to be less affected by social desir-
ability bias than those given during in-person interviews
[8, 9]. This is especially the case for private information
like substance use and sexual behavior. Thus, PROs are
expected to identify more risky behaviors than physician-
reported diagnoses.
However, in many large cohorts like CNICS, only a
subset of participants may complete PROs. Nevertheless, it
is a goal of CNICS to have active patients complete the
PROs, and the responses from the subset completing the
PROs are sometimes used as data to draw inferences [10].
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Sample Selection
CNICS patients were eligible for inclusion if they attended
at least one HIV primary care visit between implementa-
tion of the PROs at one of the seven CNICS clinics col-
lecting PRO data and November 2014. Patients were
allowed to contribute multiple visits. Prior to the applica-
tion of any exclusion criteria, there were 178,877 recorded
visits contributed by 16,028 patients.
We included only visits on which a patient was likely to
be eligible to complete a PRO. Visits that occurred within
108 days of the last visit on which a patient completed a
PRO were excluded (29,947 visits), based on the CNICS
protocol that PROs can only be offered to patients at visits
more than 108 days apart. Visits were excluded if the
patient’s recorded CNICS start date occurred after the
medical record visit date (1099 visits).
Patients were excluded if they had no baseline data, e.g.
race/ethnicity, HIV risk factor, and age at baseline (6214
visits). Patients were also excluded if they were not White
non-Hispanic, Black non-Hispanic, or Hispanic because the
other non-Hispanic group was small and likely heteroge-
neous (8581 visits). After accounting for these restrictions,
14,145 patients contributing 133,036 visits were included
in this study sample.
Variable Definitions
Our main exposure was defined as receipt of at least one ‘‘at-
risk alcohol use’’ clinical diagnosis (i.e. a diagnosis recorded
by the physician in the electronic medical record but no ICD
codes were provided) within the year prior to an eligible
CNICS visit, as our best estimate of recent heavy drinking
for the full study sample given the available data. A patient
was not considered exposed if the diagnosis was received on
the day of the visit, due to concerns that completing a PRO
might prompt a patient to inform their doctor of their alcohol
misuse. Our main outcome was defined as completion of the
PRO alcohol consumption questions on the same day as an
eligible CNICS visit. The required PRO questions were as
follows: (1) how often do you have a drink containing
alcohol; (2) how many drinks containing alcohol do you
have on a typical day when you are drinking; and (3) how
often do you have five or more drinks on one occasion?
[14, 15] These are the first three questions of the Alcohol
Use Disorders Identification Test (AUDIT) questionnaire or
all of the questions on the shortened AUDIT consumption
(AUDIT-C) questionnaire. Here, a patient was considered to
have the outcome if he completed all three questions or if he
answered ‘‘Never’’ to the first question (the latter causes the
computer-based questionnaire to automatically skip the
remaining alcohol questions) [7].
It is unknown whether any specific factors affect a patient’s 
willingness to participate in completion of a PRO, and the 
subgroup completing PROs could be a select sample of the 
full cohort [11].
We sought to learn about the subsample of CNICS 
patients that complete the PROs and to determine whether 
their self-reported data is susceptible to selection bias. 
Selection bias can occur when a non-random sample is 
selected and factors associated with selection are directly 
affected by both exposure and outcome or have a common 
cause with the exposure and with the outcome [12, 13]. We 
investigated the potential for bias by assessing whether 
having received an at-risk alcohol use diagnosis, as a 
marker for heavy drinking, was associated with completion 
of the alcohol consumption questions on the CNICS PRO. 
We hypothesized that patients with an at-risk alcohol use 




We used data from CNICS, a clinic-based cohort consisting 
of over 32,000 HIV-infected adults aged 18 or older who 
sought care at one of eight clinical sites (https://www.uab. 
edu/cnics/). The study sites are located in geographically 
diverse, urban areas of the United States: Birmingham, AL; 
Baltimore, MD; Seattle, WA; San Francisco, CA; San 
Diego, CA; Chapel Hill, NC; Boston, MA; and Cleveland, 
OH.
The data center for CNICS draws together select 
information from clinic, administrative, and medical 
records as well as PROs. Patient visits occurred approx-
imately every 3–6 months (although time between visits 
varied by patient), with a goal that PROs would be filled 
out every 4–6 months [10]. The questionnaires (referred 
to by CNICS as PROs) collect information on patient 
outcomes like body morphology and HIV symptoms as 
well as patient behaviors like alcohol consumption. Cur-
rently, PROs are available at seven of the eight CNICS 
sites. Institutional review boards at each site approved 
study procedures. Participants provided written informed 
consent to be included in the CNICS cohort or con-
tributed administrative or clinical data with a waiver of 
written informed consent where approved by local insti-
tutional review board(s). This study was reviewed by the 
Office of Human Research Ethics at the University of 
North Carolina at Chapel Hill and was determined to not 
constitute human subjects research as defined under fed-
eral regulations.
We considered several covariates in our analyses.
Variables that were collected at baseline for all patients
included enrollment date, sex, race/ethnicity, study site,
and HIV risk category (i.e. injection drug user or men who
have sex with men). Variables that were updated at each
eligible HIV primary care visit were prior clinical diag-
nosis of substance use, including amphetamines, cocaine,
and opiates; whether ART had been initiated; most recent
and nadir CD4 counts; most recent and peak log10 HIV1
RNA level (viral load); age; time since PRO introduction at
study site; past completion of a PRO; and time since entry
into CNICS. To ensure we were not controlling for vari-
ables affected by exposure, all potential confounders had to
occur prior to the date on which exposure status was
recorded.
Statistical Analyses
We first assessed whether the subset completing PROs
differed from those who did not complete PROs. We
compared the distribution of patient characteristics listed
above both for first eligible visits as well as for all eligible
visits. Categorical variables were compared using a Chi
Square test, and continuous variables were compared using
a two-sample T test (both using an a level of 0.05).
In our main analysis, we used a linear binomial model to
estimate a difference in the proportion of patients com-
pleting the required PRO alcohol questions comparing
patients who had received an ‘‘at-risk alcohol use’’ diag-
nosis within one year of the eligible CNICS visit to those
who had not. A log binomial model was used to estimate a
ratio of proportions. We accounted for repeated visits using
generalized estimating equations and excluded patients
missing any covariate data; 1% of visits (1564 visits) were
excluded due to missing data.
We conducted a crude and covariate-adjusted analysis.
In our adjusted analysis, we controlled for the measured
baseline and visit-specific covariates using stabilized
inverse probability of treatment weights (IPTW) [16].
Restricted quadratic splines with four knots were used to
flexibly model continuous variables [17].
We also undertook several sensitivity analyses. First, we
assessed whether the results changed if different definitions
of the exposure and outcome were used. The alternate
exposure definition considered was receipt of an ‘‘at-risk
alcohol use’’ diagnosis at any point prior to the eligible
visit. Alternate outcome definitions examined were whe-
ther the patient initiated a PRO on the eligible visit date
and, among those who initiated a PRO, whether they
completed the alcohol questions. The linear binomial
model used in the main analysis was run for all definition
changes.
Next, we assessed the effect of exposure misclassifica-
tion. As a method of determining whether a patient has a
recent history of heavy drinking or an alcohol use disorder,
the physician-reported diagnoses are expected to be
specific but not sensitive. The most severe cases are likely
recorded, but mild or moderate cases might be missed. We
assumed the specificity of the diagnoses to be one and re-
calculated the difference in proportions by ‘‘correcting’’
our weighted counts of exposed and unexposed events and
totals for a range of sensitivities between 0.25 and 1. The
lower bound was chosen based on the smallest estimate
found for the percent of alcoholics whose disorder was
detected by their physician, and the upper bound reflects
the assumed sensitivity in the main analysis [18, 19]. All
statistical analyses were carried out in SAS software ver-
sion 9.4 (SAS Institute Inc., Cary, NC).
Results
At their first eligible visit, 18.4% of eligible patients
completed the required PRO alcohol questions (Table 1).
Both PRO completers and non-completers were primarily
male. Completers were more likely to be both injection
drug users and MSM than non-completers. PRO-com-
pleters were more likely to be Black non-Hispanic and less
likely to be Hispanic than non-completers (35.9 and 32.0%
Black, respectively; 11.4 and 17.5% Hispanic). Mean ages
at baseline and visit were comparable. Patients completing
the PROs had slightly higher most recent CD4 cell counts,
lower nadir CD4 cell counts, lower recent viral loads, but
similar peak viral loads as non-completers. Greater time
had elapsed since study entry and since PRO implemen-
tation at the study site for completers than non-completers.
Compared to non-completers, patients completing the
PROs were more likely to be on ART (79.4% of completers
and 70.8% of non-completers). Distributions of past sub-
stance use diagnoses were similar.
Patients completed the PRO alcohol questions at 20.8%
of all eligible HIV primary care visits (Table 2). Similar
distributions for baseline patient characteristics were
observed as for first visits. Visits where the alcohol ques-
tions were completed were less likely to be contributed by
patients with a history of substance use for all drugs
examined and more likely to be contributed by patients on
ART. Visits where PROs were completed were also more
likely to be contributed by a patient who had completed a
PRO in the past (68.1% of completion visits and 19.0% of
non-completion visits). The completion and non-comple-
tion subsamples had nearly identical CD4 cell counts and
viral loads. The age distributions were comparable. Visits
where PROs were completed occurred, on average, more
years after the PROs were implemented than non-com-
pletion visits (3.1 years and 2.4 years, respectively).
In the main analysis, 21.0% of those unexposed to and
15.8% of those exposed to an at-risk alcohol use diagnosis
within the year prior to a CNICS HIV primary care visit
completed the PRO alcohol questions on the day of said
visit (Table 3). Comparing exposed to unexposed patients,
the crude difference in PRO-completion proportions was
-5.2% (95% CI -6.6 to -3.8%). After adjusting for
confounding, the difference in the percent of patients
completing the alcohol questions was -3.2% (95% CI
-5.6 to -0.8%) comparing exposed to unexposed patients.
In the alternate definition analyses (Table 4), when any
prior receipt of an at-risk alcohol use diagnosis was the
exposure, estimates were closer to the null (crude -1.5%,
95% CI -2.7 to -0.4%; weighted -1.3%, 95% CI -2.6 to
-0.0%). Using PRO initiation as the outcome did not
substantially change the difference in proportion estimates.
With the main analysis exposure definition, the crude dif-
ference in PRO completion proportions was -5.1% (95%
CI -6.6 to -3.7%), and the weighted difference was
-3.1% (95% CI -5.6 to -0.6%).
Within the group of visits where a PRO was initiated
94.1% of visits contributed by a patient with an at-risk
alcohol diagnosis in the year prior met this outcome
criterion.
Lastly, in the analysis assessing the effects of non-dif-
ferential exposure misclassification, adjustment of the
weighted visits resulted in estimates that were further from
the null (Table 5). The distance from the observed estimate
increased as the sensitivity decreased; however, changes
were small. At the lowest sensitivity of 0.25, the adjusted
difference in PRO-completion proportions was -3.6%,
only 0.4 percentage points lower than the estimate when
assuming perfect sensitivity.
Discussion
In this study, we estimated the difference in the proportion
of patients completing the PRO alcohol questions, com-
paring patients with an at-risk alcohol use diagnosis in the
year prior to a CNICS HIV primary care visit to those
without. We observed that PROs were completed at very
few of the assessed visits and that patients with a diagnosis
were less likely to complete the PRO alcohol questions.
However, neither the crude nor adjusted difference in
proportions indicated a particularly strong relationship
between at-risk alcohol use and completion of the PROs.
The strength of association decreased further if the expo-
sure was any prior receipt of an at-risk alcohol use diag-
nosis rather than receipt in the prior year. After adjustment
for exposure misclassification, estimates were further from
Table 1 Baseline characteristics by PRO alcohol question completion, at first eligible visit and all eligible visits














1371 (52.7) 5824 (50.5) \0.0001 14,267 (51.6) 57,339 (54.4) \0.0001
Black non-
Hispanic
933 (35.9) 3698 (32.0) 9276 (33.5) 26,273 (24.9)
Hispanic 297 (11.4) 2022 (17.5) 4125 (14.9) 21,756 (20.7)
HIV risk category, n (%)
MSM 1625 (63.2) 7372 (64.8) 0.0007 17,804 (65.0) 69,578 (66.9) \0.0001
IDU 170 (6.6) 745 (6.6) 1420 (5.2) 8158 (7.8)
Both 136 (5.3) 405 (3.6) 1287 (4.7) 3969 (3.8)
Other 641 (24.9) 2854 (25.1) 6901 (25.2) 22,355 (21.5)
Baseline age,
mean (SD)
39.7 (10.4) 39.7 (10.5) 0.8 39.8 (10.1) 40.2 (10.0) \0.0001
CNICS Center for AIDS Research Network of Integrated Clinical Systems, HIV human immunodeficiency virus, MSM men who have sex with
men, IDU injection drug user, SD standard deviation
(28,624 visits), the difference in proportions of patients 
completing the alcohol questions was attenuated compared 
to the main analysis results. For the main analysis exposure 
definition, the crude difference was -1.8% (95% CI -3.6 
to 0.1%), and the weighted difference was -1.6% (95% CI 
-4.2 to 1.1%). Patients were highly likely to complete the 
alcohol questions if they had already initiated the PRO;
Table 2 Visit-specific characteristics by PRO alcohol question completion, at first eligible visit and all eligible visits










Age at visit, mean (SD) 42.6 (10.7) 42.3 (10.8) 0.3 44.5 (10.5) 44.7 (10.5) 0.006
Past year alcohol diagnosis,
n (%)
89 (3.4) 468 (4.1) 0.1 778 (2.8) 4141 (3.9) \0.0001
Any prior alcohol diagnosis,
n (%)
417 (16.0) 1614 (14.0) 0.007 4701 (17.0) 19,300 (18.3) \0.0001
Any prior cocaine
diagnosis, n (%)
314 (12.1) 1476 (12.8) 0.3 3206 (11.6) 15,107 (14.3) \0.0001
Any prior amphetamine
diagnosis, n (%)
287 (11.0) 1163 (10.1) 0.1 3228 (11.7) 15,718 (14.9) \0.0001
Any prior opiates diagnosis,
n (%)
99 (3.8) 472 (4.1) 0.5 1051 (3.8) 7032 (6.7) \0.0001
On ART, n (%) 2066 (79.4) 8167 (70.7) \0.0001 25,429 (91.9) 93,914 (89.1) \0.0001
CD4 counts, mean (SD)
Most recent 500.6 (298.5) 486.2 (297.9) 0.03 545.7 (301.7) 520.1 (300.1) \0.0001
Nadir since baseline 294.1 (245.4) 310.2 (254.2) 0.004 255.0 (216.1) 261.0 (216.2) \0.0001
Log10 viral load, mean (SD)
Most recent 2.5 (1.4) 2.7 (1.4) \0.0001 2.1 (1.0) 2.3 (1.1) \0.0001
Peak since baseline 4.3 (1.4) 4.2 (1.4) 0.08 4.5 (1.3) 4.5 (1.3) 0.0002
Past PRO completion, n (%) 0 (0.0) 0 (0.0) 18,836 (68.1) 19,969 (19.0) \0.0001
Years since PRO
introduction, mean (SD)
1.7 (1.8) 1.5 (1.8) \0.0001 3.1 (1.7) 2.4 (1.7) \0.0001
Years since entry into
CNICS, mean (SD)
3.3 (3.6) 3.0 (3.7) 0.0002 5.2 (4.0) 5.0 (4.1) \0.0001
CNICS Center for AIDS Research Network of Integrated Clinical Systems, SD standard deviation, ART antiretroviral therapy, PRO patient
reported outcomes
Table 3 Association between receipt of an at-risk alcohol use diagnosis in the year prior to a CNICS HIV primary care visit and completion of













Alcohol diagnosis in past
year
4889 774 0.158 -0.052 -0.066,
-0.038
0.75 0.69, 0.82
No alcohol diagnosis in
past year
126,583 26,638 0.210 0 Reference 1 Reference
Weighted analysisa
Alcohol diagnosis in past
year
4821 855 0.177 -0.032 -0.056,
-0.008
0.85 0.74, 0.97
No alcohol diagnosis in
past year
125,842 26,384 0.210 0 Reference 1 Reference
CNICS Center for AIDS Research Network of Integrated Clinical Systems, HIV human immunodeficiency virus, PRO patient reported outcomes,
No. number, Prop. proportion, CI confidence interval
a Stabilized inverse probability of treatment weights were used to control for confounding by sex, race/ethnicity, study site, HIV risk category,
prior substance use diagnoses, ART initiation, most recent and peak CD4 counts, most recent and nadir log10 viral load, age, time since PRO
introduction at study site, past completion of a PRO, and time since entry into CNICS
adherence [3, 20]. Thus, patients who misuse alcohol tend
to see worse clinical HIV outcomes.
PROs can be a powerful way to collect alcohol use data.
These self-reported questionnaires are rich sources of
timely data and can be implemented in clinical settings
with minimal burden on patients and staff (www.acade
myhealth.org/files/2012/sunday/crane2.pdf). In addition,
they are less subject to social desirability bias than in-
person interviews [8, 9]. CNICS uses the validated AUDIT
and AUDIT-C surveys to detect problem drinking in their
PROs [14, 15]. AUDIT is especially useful because it was
designed to catch drinking problems before they progress
to severe dependence or alcoholism [21].
However, when selection of patients to complete PROs
is self-determined, selection bias may arise. Any measure
of association may be biased if factors associated with













Main outcome definition: all alcohol PRO questions completed
Alternate exposure definition 1
Any prior alcohol
diagnosis






107,596 22,733 0.211 0 Reference 0 Reference










126,583 27,801 0.220 0 Reference 0 Reference
Alternate exposure definition 1
Any prior alcohol
diagnosis






107,596 23,680 0.220 0 Reference 0 Reference










27,801 26,638 0.958 0 Reference 0 Reference
Alternate exposure definition 1
Any prior alcohol
diagnosis






23,680 22,733 0.960 0 Reference 0 Reference
PRO patient reported outcomes, No. number, Prop. proportion, RD risk difference, CI confidence interval
a Stabilized inverse probability of treatment weights were used to control for confounding by sex, race/ethnicity, study site, HIV risk category,
prior substance use diagnoses, ART initiation, most recent and peak CD4 counts, most recent and nadir log10 viral load, age, time since PRO
introduction at study site, past completion of a PRO, and time since entry into CNICS
the null, though still small. When examining patients who 
initiated a PRO, we saw a high proportion of completion of 
the alcohol questions in both exposure groups.
These findings are informative for researchers working 
in CNICS and related settings. Alcohol consumption is 
often a variable of interest in studies of people living with 
HIV due to the high prevalence of heavy drinking and 
alcohol use disorders in this population [1, 2]. Some studies 
have reported that the level of heavy drinking in people 
living with HIV is twice the level in the general US pop-
ulation [2]. Moreover, alcohol use has been found to be 
adversely associated with HIV disease progression. Alco-
hol misuse can lead to tissue inflammation, immune dys-
regulation, increased viral replication, and higher 
susceptibility to opportunistic infections [1, 3, 4, 20]. 
Alcohol use is also associated with decreased ART
selection are affected by or have a common cause with the
exposure and are affected by or have a common cause with
the outcome [12]. In other words, selection bias can be
considered a type of collider stratification bias [13].
The bias can also be framed as a missing data problem.
If a researcher uses the PRO data, some CNICS patients
will not have answered the alcohol questions or will not be
included. Bias can occur when, as above, the missingness is
a collider [12]. Additionally, we suspect that the alcohol
data is ‘‘missing not at random,’’ i.e. the missingness is
associated with the unmeasured alcohol consumption.
Unlike other types of missing data, ‘‘missing not at ran-
dom’’ typically cannot be controlled for using multiple
imputation or inverse probability of missingness weights
[12, 22]. Researchers can explore the effects of data
missing not at random in sensitivity analyses [23].
There are several strengths of our study. We were able
to examine the association between alcohol-related diag-
noses and PRO completion in over 130,000 patient-visits
contributed by more than 14,000 HIV-positive patients.
CNICS collects data in the whole cohort and in a subset,
which allowed us to examine the PRO selection process
and the potential for selection bias. We were able to control
for a variety of baseline and visit-specific patient charac-
teristics. Furthermore, CNICS is fairly representative of the
population of newly diagnosed HIV patients in the United
States [24].
This study had several limitations. We could not account
for mental health diagnoses, which we believe could be
confounders of the association between at-risk alcohol use
and PRO completion. It is probable that there were other,
unmeasured confounders, as it is nearly impossible to
measure all components of a ‘‘healthy lifestyle.’’ Further-
more, we were limited in the type of sensitivity analyses
we could conduct. For example, it would have been
informative to use a biomarker as an alternate exposure
definition, but there were no available laboratory correlates
for recent or chronic heavy drinking. We were also limited
by the fact that we only had record of a clinical diagnosis
for ‘‘at-risk alcohol use,’’ rather than more specific ICD
codes. Due to this, we could not look at the differences in
completion by different alcohol diagnoses.
Another limitation was that it was impossible to know at
which visits patients were actually offered a PRO to
complete. We had to use the observed data and fairly strict
exclusion criteria to try and select only those visits where a
patient was most likely to be considered eligible to com-
plete a PRO. Unfortunately, a limitation of the data was
that we could not distinguish whether a patient was con-
sidered incapable of completing a PRO at a particular visit,
as might occur if they were intoxicated, or if they simply
were not offered a PRO to complete. Our choice to exclude
patients who were not Black, White, or Hispanic could
further limit the interpretation of our results. These
Table 5 Weighted difference
in PRO-completion
proportions,a corrected for non-
differential misclassification of
at-risk alcohol use diagnoses
Sensitivity Exposed PRO completionsb, c Total exposed visitsb, c Weighted difference in prop.c
1.00 855 4821 -0.032
0.95 900 5075 -0.032
0.90 950 5357 -0.032
0.85 1006 5672 -0.033
0.80 1069 6026 -0.033
0.75 1140 6428 -0.033
0.70 1222 6887 -0.033
0.65 1316 7417 -0.033
0.60 1425 8035 -0.033
0.55 1555 8766 -0.033
0.50 1710 9642 -0.034
0.45 1900 10,714 -0.034
0.40 2138 12,053 -0.034
0.35 2443 13,775 -0.035
0.30 2851 16,071 -0.035
0.25 3421 19,285 -0.036
RD risk difference, Prop. proportion
a Defined as completion of the required three alcohol questions
b Exposure in this analysis was receipt of an at-risk alcohol use diagnosis within the year prior to the
eligible CNICS visit
c Counts and differences in proportions were weighted by stabilized inverse probability of treatment
weights
individuals could have been more likely to have alcohol
diagnoses and even less likely to complete a PRO. How-
ever, in the CNICS, this race/ethnicity group is very small
(less than 8% of the cohort), so their exclusion was unlikely
to greatly affect our results.
Also, because we looked only at patients who arrived at
their visits, our study does not address the issue of lower
retention in care among CNICS patients who are heavy
drinkers, which is another potential source of selection bias
that researchers need to consider when working with the
alcohol data [25]. Lastly, there was no way to determine
whether a patient filled out the PRO accurately. It is pos-
sible that those who misuse alcohol (some of whom may
not have a clinical diagnosis for at-risk alcohol use) are
more likely to misrepresent their alcohol consumption
when completing the PROs. For a researcher using the
PRO alcohol data, this misclassification may be as
important as any selection bias incurred from heavy drin-
kers not completing the PROs.
There are several further steps that could be taken to
continue examining PRO completion in this cohort. First,
our analysis could be repeated for other variables in the
PRO data, to assess whether use of those variables as an
exposure or confounder could result in bias. Second, one
could delve deeper into the relationship between receipt of
alcohol diagnoses and PRO completion by considering
exposure trajectories (i.e. compare patients who had many
diagnoses since enrollment into CNICS to those with few).
This might shed light on the relationship between long-
term drinking behavior and patterns of PRO completion.
Our goal in this paper was to explore the potential selection
bias resulting from differences in PRO completion and to
quantify that bias to inform sensitivity analyses. We chose
the best available marker of recent heavy drinking avail-
able for the entire cohort as an example variable that could
be associated with differences in PRO completion.
Conclusions
That we observed an association between receipt of an at-
risk alcohol use diagnosis and completion of the PROs,
even after controlling for a variety of patient
characteristics, supports the theory that the data may be
missing not at random. However, the strength of associ-
ation was modest. We are not suggesting that our esti-
mated difference in proportions accurately reflects the
magnitude of the bias that will occur if the PRO alcohol
data is used as an exposure because that will depend on
factors such as the strength of the association between the
chosen outcome and PRO completion. Our estimate
could, though, provide an upper bound of the bias caused
by conditioning on a collider [26] and could be used to
inform future sensitivity analyses. More broadly, our
findings serve as information to raise awareness that the
PRO subset does differ from the entire CNICS cohort and
that a researcher may wish to pursue sensitivity analyses
for selection bias in studies that estimate effects using the
PRO alcohol data.
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Table 6 Baseline characteristics of CNICS patients at first eligible visit and all eligible visits









Male, n (%) 11,984 (84.7) 2185 (84.0) 113,974 (85.7) 23,385 (84.5)
Race/ethnicity, n (%)
Table 7 Visit-specific characteristics of CNICS patients at first eligible visit and all eligible visits









Age, mean (SD) 42.4 (10.8) 42.6 (10.7) 44.7 (10.5) 44.5 (10.5)
Past year alcohol diagnosis,
n (%)
557 (3.9) 89 (3.4) 4919 (3.7) 778 (2.8)
Any prior alcohol diagnosis,
n (%)
2031 (14.4) 417 (16.0) 24,001 (18.0) 4701 (17.0)
Any prior cocaine diagnosis,
n (%)
1790 (12.7) 314 (12.1) 18,313 (13.8) 3206 (11.6)
Any prior amphetamine
diagnosis, n (%)
1450 (10.3) 287 (11.0) 18,946 (14.2) 3228 (11.7)
Any prior opiates diagnosis,nn
(%)
571 (4.0) 99 (3.8) 8083 (6.1) 1051 (3.8)
On ART, n (%) 10,233 (72.3) 2066 (79.4) 119,343 (89.7) 25,429 (91.9)
CD4 counts, mean (SD)
Most recent 488.9 (298.0) 500.6 (298.5) 525.5 (300.6) 545.7 (301.7)
Nadir since baseline 307.2 (252.6) 294.1 (245.4) 259.7 (216.2) 255.0 (216.1)
Log10 viral load, mean (SD)
Most recent 2.7 (1.4) 2.5 (1.4) 2.2 (1.1) 2.1 (1.0)
Peak since baseline 4.3 (1.4) 4.3 (1.4) 4.5 (1.3) 4.5 (1.3)
Past PRO completion, n (%) 0 (0.0) 0 (0.0) 38,805 (29.2) 18,836 (68.1)
Years since PRO introduction,
mean (SD)
1.5 (1.8) 1.7 (1.8) 2.5 (1.7) 3.1 (1.7)
Years since entry into CNICS,
mean (SD)
3.0 (3.7) 3.3 (3.6) 5.0 (4.0) 5.2 (4.0)
CNICS Center for AIDS Research Network of Integrated Clinical Systems, SD standard deviation, ART antiretroviral therapy, PRO patient
reported outcomes
Table 6 continued











7195 (50.9) 1371 (52.7) 71,606 (53.8) 14,261 (51.6)
Black non-
Hispanic
4631 (32.7) 933 (35.9) 35,549 (26.7) 9276 (33.5)
Hispanic 2319 (16.4) 297 (11.4) 25,881 (19.5) 4125 (14.9)
HIV risk category, n (%)
MSM 8997 (64.5) 1625 (63.2) 87,382 (66.5) 17,804 (65.0)
IDU 915 (6.6) 170 (6.6) 9578 (7.3) 1420 (5.2)
Both 541 (3.9) 136 (5.3) 5256 (4.4) 1287 (4.7)
Other 3495 (25.1) 641 (24.9) 29,256 (22.3) 6901 (25.2)
CNICS Center for AIDS Research Network of Integrated Clinical Systems, HIV human immunodeficiency virus, MSM men who have sex with
men, IDU injection drug user
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